202 related articles for article (PubMed ID: 24747978)
21. Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.
Sheehan DV; Svedsäter H; Locklear JC; Eriksson H
J Affect Disord; 2013 Dec; 151(3):906-13. PubMed ID: 24135509
[TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
[TBL] [Abstract][Full Text] [Related]
23. Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.
Clayton AH; Locklear JC; Svedsäter H; McIntyre RS
CNS Spectr; 2014 Apr; 19(2):182-96. PubMed ID: 24067192
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.
Litten RZ; Fertig JB; Falk DE; Ryan ML; Mattson ME; Collins JF; Murtaugh C; Ciraulo D; Green AI; Johnson B; Pettinati H; Swift R; Afshar M; Brunette MF; Tiouririne NA; Kampman K; Stout R;
Alcohol Clin Exp Res; 2012 Mar; 36(3):406-16. PubMed ID: 21950727
[TBL] [Abstract][Full Text] [Related]
25. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial.
Potvin S; Morin M; Cloutier C; Gendron A; Bissonnette A; Marchand S
J Clin Psychopharmacol; 2012 Oct; 32(5):684-7. PubMed ID: 22926604
[TBL] [Abstract][Full Text] [Related]
26. Potential benefits of quetiapine in the treatment of substance dependence disorders.
Sattar SP; Bhatia SC; Petty F
J Psychiatry Neurosci; 2004 Nov; 29(6):452-7. PubMed ID: 15644986
[TBL] [Abstract][Full Text] [Related]
27. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
28. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
[TBL] [Abstract][Full Text] [Related]
29. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
30. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
31. Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder.
Frey BN; Haber E; Mendes GC; Steiner M; Soares CN
Arch Womens Ment Health; 2013 Feb; 16(1):83-5. PubMed ID: 23143411
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder.
Khan A; Joyce M; Atkinson S; Eggens I; Baldytcheva I; Eriksson H
J Clin Psychopharmacol; 2011 Aug; 31(4):418-28. PubMed ID: 21694613
[TBL] [Abstract][Full Text] [Related]
33. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
Gabriel A
Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
35. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
De Deyn PP; Eriksson H; Svensson H;
Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation.
Hanisch F; Friedemann J; Pillmann F
J Psychopharmacol; 2010 Nov; 24(11):1725-6. PubMed ID: 19939868
[TBL] [Abstract][Full Text] [Related]
37. Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial.
Karsten J; Hagenauw LA; Kamphuis J; Lancel M
J Psychopharmacol; 2017 Mar; 31(3):327-337. PubMed ID: 28093029
[TBL] [Abstract][Full Text] [Related]
38. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
